<DOC>
	<DOCNO>NCT02727738</DOCNO>
	<brief_summary>Evaluation efficacy combine treatment ( methimazole plus selenium ) control hyperthyroidism compare methimazole alone 30 Graves ' disease ( GD ) untreated patient .</brief_summary>
	<brief_title>Treatment Graves ' Hyperthyroidism With Selenium Plus Methimazole</brief_title>
	<detailed_description>30 untreated GD hyperthyroid patient randomize two group ( A B ) . Group A patient treated anti-thyroid drug ( methimazole ) dose aim control hyperthyroidism . Group B patient treat methimazole plus selenium ( 160 mg daily ) . Patients evaluate time 0 , 45 90 day symptom hyperthyroidism ( specific questionnaire ) , clinical status ( weight , heart rate ) , laboratory ( thyroid function test , TSHR autoantibody , serum selenium , index oxidative stress-MDA , cholesterol , SHBG ) EKG . The aim study evaluate combine treatment ( methimazole plus selenium ) effective methimazole alone control GD hyperthyroidism .</detailed_description>
	<mesh_term>Graves Disease</mesh_term>
	<mesh_term>Hyperthyroidism</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<criteria>Hyperthyroid untreated Graves ' disease patient Hyperthyroid treat Graves ' disease patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Hyperthyroidism</keyword>
	<keyword>Methimazole</keyword>
	<keyword>Selenium</keyword>
</DOC>